251 related articles for article (PubMed ID: 26686089)
1. TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle.
Zhu B; Zhang M; Williams EM; Keller C; Mansoor A; Davie JK
Oncogene; 2016 Aug; 35(32):4212-24. PubMed ID: 26686089
[TBL] [Abstract][Full Text] [Related]
2. TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.
Zhu B; Zhang M; Byrum SD; Tackett AJ; Davie JK
Int J Cancer; 2014 Aug; 135(4):785-97. PubMed ID: 24470334
[TBL] [Abstract][Full Text] [Related]
3. TBX3 represses TBX2 under the control of the PRC2 complex in skeletal muscle and rhabdomyosarcoma.
Oh TJ; Adhikari A; Mohamad T; Althobaiti A; Davie J
Oncogenesis; 2019 Apr; 8(4):27. PubMed ID: 30979887
[TBL] [Abstract][Full Text] [Related]
4. Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity.
Langdon CG; Gadek KE; Garcia MR; Evans MK; Reed KB; Bush M; Hanna JA; Drummond CJ; Maguire MC; Leavey PJ; Finkelstein D; Jin H; Schreiner PA; Rehg JE; Hatley ME
Nat Commun; 2021 Sep; 12(1):5520. PubMed ID: 34535684
[TBL] [Abstract][Full Text] [Related]
5. EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma.
Mohamad T; Kazim N; Adhikari A; Davie JK
Oncotarget; 2018 Apr; 9(26):18084-18098. PubMed ID: 29719592
[TBL] [Abstract][Full Text] [Related]
6. Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma.
Burgucu D; Guney K; Sahinturk D; Ozbudak IH; Ozel D; Ozbilim G; Yavuzer U
BMC Cancer; 2012 Oct; 12():481. PubMed ID: 23082988
[TBL] [Abstract][Full Text] [Related]
7. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
[TBL] [Abstract][Full Text] [Related]
8. Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.
Rodriguez M; Aladowicz E; Lanfrancone L; Goding CR
Cancer Res; 2008 Oct; 68(19):7872-81. PubMed ID: 18829543
[TBL] [Abstract][Full Text] [Related]
9. The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.
Li J; Ballim D; Rodriguez M; Cui R; Goding CR; Teng H; Prince S
J Biol Chem; 2014 Dec; 289(51):35633-43. PubMed ID: 25371204
[TBL] [Abstract][Full Text] [Related]
10. Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.
Zhang M; Truscott J; Davie J
Mol Cancer; 2013 Nov; 12(1):150. PubMed ID: 24279793
[TBL] [Abstract][Full Text] [Related]
11. Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells.
Wan X; Helman LJ
Oncogene; 2003 Nov; 22(50):8205-11. PubMed ID: 14603261
[TBL] [Abstract][Full Text] [Related]
12. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound.
Cen L; Hsieh FC; Lin HJ; Chen CS; Qualman SJ; Lin J
Br J Cancer; 2007 Sep; 97(6):785-91. PubMed ID: 17848913
[TBL] [Abstract][Full Text] [Related]
13. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J
Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366
[TBL] [Abstract][Full Text] [Related]
14. The transcription elongation factor TCEA3 induces apoptosis in rhabdomyosarcoma.
Kazim N; Adhikari A; Oh TJ; Davie J
Cell Death Dis; 2020 Jan; 11(1):67. PubMed ID: 31988307
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
16. PAX3 and PAX3-FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN.
Li HG; Wang Q; Li HM; Kumar S; Parker C; Slevin M; Kumar P
Cancer Lett; 2007 Aug; 253(2):215-23. PubMed ID: 17350164
[TBL] [Abstract][Full Text] [Related]
17. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.
Vance KW; Carreira S; Brosch G; Goding CR
Cancer Res; 2005 Mar; 65(6):2260-8. PubMed ID: 15781639
[TBL] [Abstract][Full Text] [Related]
18. miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma.
Diao Y; Guo X; Jiang L; Wang G; Zhang C; Wan J; Jin Y; Wu Z
J Biol Chem; 2014 Jan; 289(1):529-39. PubMed ID: 24247238
[TBL] [Abstract][Full Text] [Related]
19. TBX3 and its splice variant TBX3 + exon 2a are functionally similar.
Hoogaars WM; Barnett P; Rodriguez M; Clout DE; Moorman AF; Goding CR; Christoffels VM
Pigment Cell Melanoma Res; 2008 Jun; 21(3):379-87. PubMed ID: 18444963
[TBL] [Abstract][Full Text] [Related]
20. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis.
Cai CL; Zhou W; Yang L; Bu L; Qyang Y; Zhang X; Li X; Rosenfeld MG; Chen J; Evans S
Development; 2005 May; 132(10):2475-87. PubMed ID: 15843407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]